MIRA INFORM REPORT

 

 

Report Date :

02.02.2008

 

IDENTIFICATION DETAILS

 

Name :

BEACON DIAGNOSTICS PRIVATE LIMITED

 

 

Registered Office :

424, New G.I.D.C. Estate, Phase II, Kabilpore, Navsari - 396 424, Gujarat

 

 

Country :

India

 

 

Financials (as on) :

31.03.2007

 

 

Date of Incorporation :

15.05.1990

 

 

Com. Reg. No.:

04-13764

 

 

CIN No.:

[Company Identification No.]

U24232GJ1990PTC013764

 

 

TAN No.:

[Tax Deduction & Collection Account No.]

SRTB00057B / SRTB01237F

 

 

PAN No.:

[Permanent Account No.]

AABCB2080R

 

 

Legal Form :

Private Limited Liability Company

 

 

Line of Business :

Manufacturing and Marketing of Diagnostic Kits and Reagents.

 

 

RATING & COMMENTS

 

MIRA’s Rating :

Ba

 

RATING

STATUS

PROPOSED CREDIT LINE

41-55

Ba

Overall operation is considered normal. Capable to meet normal commitments.

Satisfactory

 

Maximum Credit Limit :

USD 69000

 

 

Status :

Satisfactory

 

 

Payment Behaviour :

Regular

 

 

Litigation :

Clear

 

 

Comments :

Subject is a well established and reputed company having satisfactory track. Trade relations are fair. Business is active. Payments are reported as usually correct and as per commitments.

 

The company can be considered normal for business dealings at usual trade terms and conditions.

 

Mr. Jignesh Patel, Accounts Manager of the company confirmed that they do not have their own R & D / Design Centre. 

 

 

LOCATIONS

           

Registered Office / Plant / Administrative Office :

424, New G.I.D.C. Estate, Phase II, Kabilpore, Navsari - 396 424, Gujarat, India

Tel. No.:

91-2637-250590 / 244790 / 244791 / 244990

Fax No.:

91-2637-265105 / 250493

E-Mail :

info@beaconindia.com

sales@beaconindia.com

beacon@bom8.vsnl.net.in

Website :

http://www.beaconindia.com

 

 

DIRECTORS

 

Name :

Dr. Desai B. Dinkarbhai

Designation :

Chairman

Address :

1/1, Bima Nagar, Satellite Road, Ahmedabad – 380015, Gujarat

Date of Birth/Age :

01/02/1941

Qualification :

PhD

Date of Appointment :

15/05/1990

 

 

Name :

Dr. Joshi Kalidas Dineshchandra

Designation :

Managing Director

Address :

89, Pratikhsa Society, Gandevi Road, Navsari – 396445, Gujarat

Date of Birth/Age :

31/07/1960

Qualification :

PhD

Date of Appointment :

15/05/1990

 

 

Name :

Mr. Shetaji M. Narendra

Designation :

Finance Director

Address :

Pushpak Building, Pratiksha Society, Navsari – 396445, Gujarat

Date of Birth/Age :

13/11/1941

Qualification :

FCA

Date of Appointment :

31/05/1990

 

 

Name :

Ms. Swati Shethji

Designation :

Additional Director

Address :

2, Pratiksha Society, Opposite Vidhyakunj School, Navsari Town, Navsari – 396445, Gujarat, India

Date of Birth/Age :

26.07.1948

Date of Appointment :

22.06.2006

 

 

KEY EXECUTIVES

 

Name :

Mr. Kashya Vyas

Designation :

Company Secretary

Address :

307/308, Rajkamal Plaza- B, Behind Samruddhi Complex, Navjivan P. O. Ahmedabad – 380014, Gujarat

Qualification :

B.Com, LLM, FCS

 

 

Name :

D N Nandania and Associates

Designation :

Company Secretary

Address :

301/B, Helix Complex, Raj Trade Centre, Opposite Hotel Surya, Sayajiganj, Baroda – 390005

Tel No.:

91-265-2362316 / 2372208

Email :

Dnncs1953@yahoo.co.in

 

 

MAJOR SHAREHOLDERS / SHAREHOLDING PATTERN

 

Names of Shareholders

 

No. of Shares

Joshi Kalidas Dineshchandra

 

540

Desai Bhikubhai Dinkarbhai

 

1450

Desai Dinkarbhai Shilpa

 

270

Patel Yagneshbhai

 

575

Narendra Shethji Joint With Swatiben Shethji

 

1180

Anant N Shethji

 

370

Saudamini Shethji

 

720

Vandana Joshi

 

1255

Pranav N Shethi

 

510

C R Shah Joint With Sudhir Shah

 

200

Dhwani P Shethji

 

250

Maltiben Parekh

 

200

Chirag D Joshi

 

650

Akash Joshi

 

650

 

 

 

Equity Share Breakup

 

Percentage of Holding

Category

 

 

Directors or relatives of directors

 

88.00

Other top fifty shareholders

 

12.00

Total

 

100.00

 

 

BUSINESS DETAILS

 

Line of Business :

Manufacturing and Marketing of Diagnostic Kits and Reagents

 

 

Products :

ITC Code No.

Product Description

3822.00

Diagnostic Reagents

3005.90

Agglutinating Sera

3002.00

Other Bacteriological Products

 

 

Imports :

 

Countries :

Europe and USA

 

 

Terms :

 

Purchasing :

L/C (90 days) terms

 

PRODUCTION STATUS

 

Particulars

Unit

 

Installed Capacity

Diagnostic Reagents

Ltrs.

 

150000

 

 

GENERAL INFORMATION

 

Customers :

  • Pathological laboratories
  • Government/semi Government Hospitals
  • Private hospitals and clinics
  • Primary Health centres
  • Research Institutions
  • Colleges

 

 

No. of Employees :

195

 

 

Bankers :

  • Bank of Baroda, Panch Hatdi Branch, Navsari -  396445, Gujarat, India
  • ICICI Bank

                                   

 

 

Banking Relations :

Satisfactory

 

 

Auditors :

 

Name :

B. M. Saraf and Company

Chartered Accountants

Address :

201, Swayam Complex, Near Vipul Dudhia, Stadium Circle, Navrangpura, Ahmedabad – 380009, Gujarat, India

 

 

Associates/Subsidiaries :

Nil

 

 

CAPITAL STRUCTURE

 

Authorised Capital :

No. of Shares

Type

Value

Amount

25000

Equity Shares

Rs.100/-  each

Rs. 2.500 millions

 

Issued, Subscribed & Paid-up Capital :

No. of Shares

Type

Value

Amount

12090

Equity Shares

Rs.100/-  each

Rs. 1.209 millions

 

 

FINANCIAL DATA

[all figures are in Rupees Millions]

 

 

ABRIDGED BALANCE SHEET

 

SOURCES OF FUNDS

 

 

31.03.2007

31.03.2006

SHAREHOLDERS FUNDS

 

 

 

1] Share Capital

 

1.209

1.209

2] Share Application Money

 

0.000

0.000

3] Reserves & Surplus

 

16.087

12.083

4] (Accumulated Losses)

 

0.000

0.000

NETWORTH

 

17.296

13.292

LOAN FUNDS

 

 

 

1] Secured Loans

 

11.670

10.481

2] Unsecured Loans

 

5.259

5.363

TOTAL BORROWING

 

16.929

15.844

DEFERRED TAX LIABILITIES

 

0.561

0.650

 

 

 

 

TOTAL

 

34.786

29.786

 

 

 

 

APPLICATION OF FUNDS

 

 

 

 

 

 

 

FIXED ASSETS [Net Block]

 

6.093

5.567

Capital work-in-progress

 

0.000

0.000

 

 

 

 

INVESTMENT

 

0.001

0.001

DEFERREX TAX ASSETS

 

0.000

0.000

 

 

 

 

CURRENT ASSETS, LOANS & ADVANCES

 

 

 

 

Inventories

 

13.366

12.423

 

Sundry Debtors

 

29.437

21.430

 

Cash & Bank Balances

 

0.257

0.364

 

Other Current Assets

 

0.000

0.000

 

Loans & Advances

 

2.523

2.297

Total Current Assets

 

45.583

36.514

Less : CURRENT LIABILITIES & PROVISIONS

 

 

 

 

Current Liabilities

 

13.897

10.308

 

Provisions

 

2.994

1.988

Total Current Liabilities

 

16.891

12.296

Net Current Assets

 

28.692

24.218

 

 

 

 

MISCELLANEOUS EXPENSES

 

0.000

0.000

 

 

 

 

TOTAL

 

34.786

29.786

 


PROFIT & LOSS ACCOUNT

 

PARTICULARS

 

 

31.03.2007

31.03.2006

Sales Turnover and Other Income

 

97.411

62.875

Total Income

 

97.411

62.875

 

 

 

 

Profit/(Loss) Before Tax

 

6.858

4.206

Provision for Taxation

 

2.551

1.576

Profit/(Loss) After Tax

 

4.307

2.630

 

 

 

 

Export Value

 

2.588

1.274

 

 

 

 

Imports Value

 

21.610

6.321

 

 

 

 

Expenditures :

 

 

 

 

Financial Charges and Depreciation 

 

2.935

2.256

 

Other Expenditure

 

87.618

56.413

Total Expenditure

 

90.553

58.669

 

KEY RATIOS

 

PARTICULARS

 

 

 

31.03.2007

31.03.2006

PAT / Total Income

(%)

 

4.42

4.18

 

 

 

 

 

Net Profit Margin

(PBT/Sales)

(%)

 

7.04

6.69

 

 

 

 

 

Return on Total Assets

(PBT/Total Assets}

(%)

 

13.27

10.00

 

 

 

 

 

Return on Investment (ROI)

(PBT/Networth)

 

 

0.40

0.32

 

 

 

 

 

Debt Equity Ratio

(Total Liability/Networth)

 

 

1.96

2.12

 

 

 

 

 

Current Ratio

(Current Asset/Current Liability)

 

 

2.70

2.97

 

 

LOCAL AGENCY FURTHER INFORMATION

 

 

Bankers Charges Report as per Registry

 

           

Name of the company

BEACON DIAGNOSTICS PRIVATE LIMITED

Presented By

Bank of Baroda, Panch Hatdi Branch, Navsari -  396445, Gujarat, India

1) Date and description of instrument creating the change

Instruments of Hypothecation agreement date 16.10.1990

2) Amount secured by the charge/amount owing on the securities of charge

Rs. 0.150 Million

3) Short particular of the property charged. If the property acquired is subject to charge, date of the acquired of the property should be given

Lease hold land at Plot No. 424 and 425 in Navsari area Block No. 199/1, 166/1 at Sisodeno Ganesh, vta Navsari and construction thereon

 

Hypothecation of movable machinery, goods i.e. chemicals packing materials, finished  goods and book debts.

4) Gist of the terms and conditions and extent and operation of the charge.

Margin 25 % on Stock / Goods

40 % on Book debts

 

Interest 0.50 % Below BPLR i.e. 10.00 % p.a. on monthly rest subject to change from time to time as on directives of Bank

5) Name and Address and description of the person entitled to the charge.

Bank of Baroda, Panch Hatdi Branch, Navsari -  396445, Gujarat, India

6) Date  and brief description of instrument modifying the charge

Instruments of Hypothecation Agreement dated 18.04.2005

7) Particulars of modifications specifying the terms and conditions or the extent of operations of the charge in which modification is made and the details of the modification.

Charges stand revised as under :

 

Term Loan

Existing Rs.

Revised Rs.

Term Loan

49.15

49.15

Term Loan [New]

2.00

2.00

Cash Credit

70.00

70.00

Bill Purchased

5.00

5.00

Foreign/ Inland letter of Credit 

50.00

50.00

Total

176.15

176.15

 

 

Corporate identity number of the company

U24232GJ1990PTC013764

Name of the company

BEACON DIAGNOSTICS PRIVATE LIMITED

Address of the registered office or of the principal place of  business in India of the company

424, New G.I.D.C. Estate, Phase II, Kabilpore, Navsari - 396 424, India

This form is for

Modification of charge

Type of charge

Equitable mortgage or mortgage of property by deposition the title deeds

Particular of charge holder

Bank of Baroda, Panch Hatdi Branch, Navsari -  396445, Gujarat, India

Nature of instrument creating charge

Memorandum of title deeds

Date of instrument Creating the charge

17.10.1996

Amount secured by the charge

Rs. 2.568 Millions

Brief of the principal terms an conditions and extent and operation of the charge

Rate of interest 1 % below BPLR i.e. 50 %

Margin 25 % on stock and 40 % on Book debts

Description of the property charged indicating whether it is a charged on

  • Immovable properties
  • Plant and Machinery
  • Stock in trade
  • Book debts

Particulars of the property charged

At companies Registered Office

Brief description of the instrument modifying the charge under section 135

Memorandum of title deeds

Date of instrument modifying the charge

16.03.2006

Particulars of the present modification

Enhanced cash credit limit from Rs. 7.500 Millions to Rs. 12.500 Millions

 

 

It is in trade terms with:

 

v      The Bombay Glass Blowing Industries

v      Microlit Instruments, Lucknow, Uttar Pradesh

v      Pharma Electric Instruments Private Limited

 

Its product range includes:

 

v      Immunohematology Reagents

v      Glucose

v      Alkaline Phosphatase

v      Amylase

v      Bilirubin

v      Cholesterol

v      Creatinine

v      SGOT

v      Urea

v      Uric Acid

v      Microbial Sensitivity Discs

v      Stains and Indicators

 

Subject is accredited with ISO 9001:2000 Certification and also accredited with Special Recognition Award 1998.

 

 

AS PER WEBSITE

 

Research & Development


Continuous Research and Development work for Diagnostic products & it's Marketing is their core philosophy.

 

Management


The company is managed professionally by learned and well experienced Board of Directors as well as well experienced Production and Marketing Professionals.

 

Products Promotion


Products are promoted & marketed through their own Professional and well trained field staff all over India. At present  marketing field staff strength is of 150 people which includes sales & service engineers in each & every provience of India.

 

Distribution network


The products are distributed well all over the country through the outlets of their Authorised Stockists. Their present distribution network strength is of 350 stockists.

 

Keyperson

 

Chairman - Dr. D. B. Desai

 

Achieved doctorate from Mississippi State University, U.S.A. in 1975 and associated with R & D work for five years in U.S.A.  He is associated in business since 1980.

 

Managing Director - Dr. D. K. Joshi

 

Completed education in 1980 and associated with Diagnostic Companies since 1980 and worked as Research Scientist and also as Production In Charge of Diagnostic products. He has travelled extensively in India and abroad. He has a global  exposure in the field of Diagnostics. He also has an exposure through specialised training in Diagnostic and participated in various technological conferences and seminars including publications of papers both in India and Abroad (U.S.A., U.K., France etc.). He has completed many projects in Research and successfully commercialised them in India.

 

Finance Director - Mr. N. M. Shethji

 

A practicing chartered Accountant by profession, and associated with Diagnostics and Pharmaceutical Industries since more than 20 years.

 

 

 


CMT REPORT (Corruption, Money Laundering & Terrorism]

 

The Public Notice information has been collected from various sources including but not limited to: The Courts, India Prisons Service, Interpol, etc.

 

1]         INFORMATION ON DESIGNATED PARTY

No records exist designating subject or any of its beneficial owners, controlling shareholders or senior officers as terrorist or terrorist organization or whom notice had been received that all financial transactions involving their assets have been blocked or convicted, found guilty or against whom a judgement or order had been entered in a proceedings for violating money-laundering, anti-corruption or bribery or international economic or anti-terrorism sanction laws or whose assets were seized, blocked, frozen or ordered forfeited for violation of money laundering or international anti-terrorism laws.

 

2]         Court Declaration :

No records exist to suggest that subject is or was the subject of any formal or informal allegations, prosecutions or other official proceeding for making any prohibited payments or other improper payments to government officials for engaging in prohibited transactions or with designated parties.

 

3]         Asset Declaration :

No records exist to suggest that the property or assets of the subject are derived from criminal conduct or a prohibited transaction.

 

4]         Record on Financial Crime :

            Charges or conviction registered against subject:                                                  None

 

5]         Records on Violation of Anti-Corruption Laws :

            Charges or investigation registered against subject:                                                          None

 

6]         Records on Int’l Anti-Money Laundering Laws/Standards :

            Charges or investigation registered against subject:                                                          None

 

7]         Criminal Records

No available information exist that suggest that subject or any of its principals have been formally charged or convicted by a competent governmental authority for any financial crime or under any formal investigation by a competent government authority for any violation of anti-corruption laws or international anti-money laundering laws or standard.

 

8]         Affiliation with Government :

No record exists to suggest that any director or indirect owners, controlling shareholders, director, officer or employee of the company is a government official or a family member or close business associate of a Government official.

 

9]         Compensation Package :

Our market survey revealed that the amount of compensation sought by the subject is fair and reasonable and comparable to compensation paid to others for similar services.

 

10]        Press Report :

            No press reports / filings exists on the subject.

 

 

CORPORATE GOVERNANCE

 

MIRA INFORM as part of its Due Diligence do provide comments on Corporate Governance to identify management and governance. These factors often have been predictive and in some cases have created vulnerabilities to credit deterioration.

 

Our Governance Assessment focuses principally on the interactions between a company’s management, its Board of Directors, Shareholders and other financial stakeholders.

 

 

CONTRAVENTION

 

Subject is not known to have contravened any existing local laws, regulations or policies that prohibit, restrict or otherwise affect the terms and conditions that could be included in the agreement with the subject.

 

 

FOREIGN EXCHANGE RATES

 

Currency

Unit

Indian Rupees

US Dollar

1

Rs.39.36

UK Pound

1

Rs.78.29

Euro

1

Rs.58.48

 

 

SCORE & RATING EXPLANATIONS

 

SCORE FACTORS

 

RANGE

POINTS

HISTORY

1~10

6

PAID-UP CAPITAL

1~10

6

OPERATING SCALE

1~10

6

FINANCIAL CONDITION

 

 

--BUSINESS SCALE

1~10

7

--PROFITABILIRY

1~10

5

--LIQUIDITY

1~10

6

--LEVERAGE

1~10

6

--RESERVES

1~10

6

--CREDIT LINES

1~10

6

--MARGINS

-5~5

-

DEMERIT POINTS

 

 

--BANK CHARGES

YES/NO

YES

--LITIGATION

YES/NO

NO

--OTHER ADVERSE INFORMATION

YES/NO

NO

MERIT POINTS

 

 

--SOLE DISTRIBUTORSHIP

YES/NO

NO

--EXPORT ACTIVITIES

YES/NO

NO

--AFFILIATION

YES/NO

NO

--LISTED

YES/NO

NO

--OTHER MERIT FACTORS

YES/NO

YES

TOTAL

 

54

 

This score serves as a reference to assess SC’s credit risk and to set the amount of credit to be extended. It is calculated from a composite of weighted scores obtained from each of the major sections of this report. The assessed factors and their relative weights (as indicated through %) are as follows:

 

Financial condition (40%)            Ownership background (20%)                 Payment record (10%)

Credit history (10%)                    Market trend (10%)                                Operational size (10%)

 


 

RATING EXPLANATIONS

 

RATING

STATUS

 

 

PROPOSED CREDIT LINE

>86

Aaa

Possesses an extremely sound financial base with the strongest capability for timely payment of interest and principal sums

 

Unlimited

71-85

Aa

Possesses adequate working capital. No caution needed for credit transaction. It has above average (strong) capability for payment of interest and principal sums

 

Large

56-70

A

Financial & operational base are regarded healthy. General unfavourable factors will not cause fatal effect. Satisfactory capability for payment of interest and principal sums

 

Fairly Large

41-55

Ba

Overall operation is considered normal. Capable to meet normal commitments.

 

Satisfactory

26-40

B

Unfavourable & favourable factors carry similar weight in credit consideration. Capability to overcome financial difficulties seems comparatively below average.

 

Small

11-25

Ca

Adverse factors are apparent. Repayment of interest and principal sums in default or expected to be in default upon maturity

 

Limited with full security

<10

C

Absolute credit risk exists. Caution needed to be exercised

 

 

Credit not recommended

NR

In view of the lack of information, we have no basis upon which to recommend credit dealings

No Rating

 

 

PRIVATE & CONFIDENTIAL : This information is provided to you at your request, you having employed MIPL for such purpose. You will use the information as aid only in determining the propriety of giving credit and generally as an aid to your business and for no other purpose. You will hold the information in strict confidence, and shall not reveal it or make it known to the subject persons, firms or corporations or to any other. MIPL does not warrant the correctness of the information as you hold it free of any liability whatsoever. You will be liable to and indemnify MIPL for any loss, damage or expense, occasioned by your breach or non observance of any one, or more of these conditions